• Mirati Therapeutics Announces Closing Of Public Offering Of Common Stock And Full Exercise Of Underwriters' Option To Purchase Additional Shares

    14 days ago - By San Diego Biotechnology

    SAN DIEGO, Jan. 14, 2020 /PRNewswire/ - Mirati Therapeutics, Inc. today announced the closing of its previously announced underwritten public offering of 3,538,462 shares of its common stock at a public offering price of $97.50 per s......
    Read more ...